Old Web
English
Sign In
Acemap
>
Paper
>
Mechanisms of Improvement of Erythropoiesis with Low Dose of Deferasirox in Low Risk Myelodysplastic Syndromes
Mechanisms of Improvement of Erythropoiesis with Low Dose of Deferasirox in Low Risk Myelodysplastic Syndromes
2017
Mathieu Meunier
S. Ancelet
Christine Lefebvre
Josiane Arnaud
Catherine Garrel
Yan Wang
Patrice Faure
Jean-Marc Moulis
B. Polack
Jean-Yves Cahn
Sophie Park
Keywords:
Cancer research
Deferasirox
Erythropoiesis
Myelodysplastic syndromes
Biology
Internal medicine
low dose
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]